Kyle J. Kinney
Jessica M. Stach
Katarina Kulhankova1†
Matthew Brown
Wilmara Salgado-Pabón- 1Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, IA, United States
- 2Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, United States
Infective endocarditis (IE) is one of the most feared and lethal diseases caused by Staphylococcus aureus. Once established, the infection is fast-progressing and tissue destructive. S. aureus of the clonal complex 5 (CC5) commonly cause IE yet are severely understudied. IE results from bacterial colonization and formation of tissue biofilms (known as vegetations) on injured or inflamed cardiac endothelium. S. aureus IE is promoted by adhesins, coagulases, and superantigens, with the exotoxins and exoenzymes likely contributing to tissue destruction and dissemination. Expression of the large repertoire of virulence factors required for IE and sequelae is controlled by complex regulatory networks. We investigated the temporal expression of the global regulators agr (RNAIII), rot, sarS, sarA, sigB, and mgrA in 8 invasive CC5 isolates and established intrinsic expression patterns associated with IE outcomes. We show that vegetation formation, as tested in the rabbit model of IE, inversely correlates with RNAIII and sarA expression during growth in Todd-Hewitt broth (TH). Large vegetations with severe sequelae arise from strains with high-level expression of colonization factors but slower transition towards expression of the exotoxins. Overall, strains proficient in vegetation formation, a hallmark of IE, exhibit lower expression of RNAIII and sarA. Simultaneous high expression of RNAIII, sarA, sigB, and mgrA is the one phenotype assessed in this study that fails to promote IE. Thus, RNAIII and sarA expression that provides for rheostat control of colonization and virulence genes, rather than an on and off switch, promote both vegetation formation and lethal sepsis.
Introduction
Staphylococcus aureus is an opportunistic pathogen that colonizes the mucosal surfaces and skin of 30-40% of the human population (Spaulding et al., 2013). It causes a wide range of illnesses, from very common superficial skin and soft tissue infections to life-threatening, invasive and fulminant diseases such as sepsis and infective endocarditis (IE) (Lowy, 1998; Boucher et al., 2010; Bergin et al., 2017). Currently, S. aureus IE develops in 5-32% of patients with S. aureus bacteremia and overall accounts for the majority of IE cases in high-income countries (Bergin et al., 2017; Fernández-Hidalgo et al., 2018; Moreau et al., 2018). S. aureus IE is also increasingly common in settings where viridans streptococci are the primary etiologic agent of IE due to a high burden of congenital heart disease (Bergin et al., 2017). Left-sided, native valve IE is the most common manifestation of S. aureus endocarditis (Werdan et al., 2014). Once established, S. aureus IE is fast-progressing and tissue destructive, leading to metastatic infections and severe systemic complications that result in 22-66% lethality even with modern medical and surgical interventions (Bergin et al., 2017; Fernández-Hidalgo et al., 2018). Without treatment, S. aureus IE is 100% lethal (Lerche et al., 2021). In fact, S. aureus infection represents an independent risk factor associated with IE in-hospital mortality (Fowler et al., 2005; Fernández-Hidalgo et al., 2012; Selton-Suty et al., 2012).
S. aureus IE results from bacterial infection of injured or inflamed cardiac endothelium, predominantly the heart valves (Werdan et al., 2014). S. aureus adhesion and colonization triggers endothelial inflammation, expression of tissue factors and fibronectin, and host factor aggregation (e.g. fibrin, fibrinogen, platelets), promoting development and growth of vegetations pathognomonic of IE. For valve colonization, S. aureus binds to extracellular matrix proteins via surface adhesins anchored to the cell wall collectively known as MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) and secreted adhesins known as SERAMs (secretable expanded repertoire adhesive molecules) (Patti et al., 1994; Bergin et al., 2017). S. aureus adhesins that contribute to cardiac valve colonization and vegetation formation include ClfA (clumping factor or fibrinogen-binding protein A) and FnBPA (fibronectin-binding protein A) (McDevitt et al., 1995; Sinha et al., 1999; Kerrigan et al., 2008). Vegetation growth and maturation is promoted by adhesins, coagulases, and superantigens. The adhesins and coagulases trigger platelet activation and aggregation. These include ClfA and FnBPs but also protein A, SdrE (serine–aspartate repeat- containing protein E), IsdB (iron-regulated surface determinant protein B), Eap (extracellular adherence protein), and coagulases Coa and vWbp (von-Willebrand factor binding protein) (Que et al., 2005; Heying et al., 2007; Bertling et al., 2012; Vanassche et al., 2012). The superantigens of the egc (enterotoxin gene cluster), TSST-1 (toxic shock syndrome toxin-1), and SEC (staphylococcal enterotoxin C) and the sphingomyelin β-toxin alter endothelial cell function and promote vegetation growth (Stach et al., 2016; Kulhankova et al., 2018; Kinney et al., 2022; Tran et al., 2022). Superantigens, hemolysins, and exoenzymes are thought to contribute to the aggressive and tissue destructive nature of S. aureus IE (King et al., 2016; Tran et al., 2022).
S. aureus utilizes intricate and complex regulatory networks to control the expression of the large repertoire of cell-surface and secreted virulence factors that promote host colonization, immune evasion, persistence, and disease development (Jenul and Horswill, 2019). This network includes multiple global regulators of virulence gene expression with some of the most prominent being the accessory gene regulator (agr) quorum-sensing system, the transcriptional regulators SarA, SarS, Rot, the SaeRS two-component system, MgrA, and the alternative sigma factor SigB (Recsei et al., 1986; Somerville and Proctor, 2009). The cell-density dependent control of adhesins and colonization factors versus exotoxins and spreading factors promotes the transition from a colonization to a dissemination phenotype (Fechter et al., 2014). Their interconnectedness within the S. aureus regulatory network has been described, but whether differences in their specific intrinsic expression correlates with disease severity in the context of S. aureus IE remains largely unexplored. This is of particular interest for S. aureus IE as strain-to-strain variation in gene regulation is common and likely one factor contributing to differences in disease presentation.
The most common S. aureus clonal groups isolated from IE patients include clonal complex (CC)5, CC8, CC30, and CC45 (Xiong et al., 2009; Nienaber et al., 2011). The CC5 background is of particular interest because of its overall association with persistent bacteremia and hematogenous complications, its high frequency in infections around the globe, and its association with deregulation of the Agr system (Xiong et al., 2009; Fernández-Hidalgo et al., 2018). Further interest in S. aureus CC5 isolates stems from their significant cause of health care-associated, methicillin-resistant infections in the Western world and from being the principal genetic background associated with full vancomycin resistance (Challagundla et al., 2018). Yet, most of the understanding of S. aureus pathogenesis and global regulation of virulence gene expression comes from the study of USA300 strains, which commonly activate the Agr system at high levels (Li et al., 2009; Montgomery et al., 2010; Grundstad et al., 2019). Recent studies have emphasized the need to acquire a greater understanding of the molecular and pathogenic mechanisms characteristic of this clonal group (King et al., 2016; Pérez-Montarelo et al., 2018; Grundstad et al., 2019). In USA100 S. aureus isolates (classified into CC5), the Agr system was confirmed to regulate production of hemolysins and proteases and to promote virulence in a murine model of skin infection (Grundstad et al., 2019). Much remains unknown regarding the pathogenesis of S. aureus CC5, in particular as it relates to IE.
Recently, a genome wide association study of S. aureus isolates from patients with bacteremia (non-IE) or IE showed that bacteremia isolates are indistinguishable genotypically from those that cause IE within clonal groups and have similar disease potential in experimental IE (Bastien et al., 2022). Differences in gene expression that may account for strain-specific disease presentation across invasive isolates was not addressed. In the present study, we used 8 methicillin-sensitive S. aureus, invasive isolates, classified into CC5 to investigate the association of IE with the expression profile of six global regulators of virulence (RNAIII [agr], rot, sarS, sarA, sigB, and mgrA). We found that vegetation formation, as tested in the rabbit model of left-sided, native valve IE, inversely correlates with RNAIII and sarA expression during growth in TH (beef heart infusion) broth. In fact, a strain deficient in RNAIII expression produced some of the largest vegetations, indicating that the RNAIII-regulated virulence genes encoded by the strain are not required for vegetation formation on native valves. However, this strain was deficient in causing systemic pathology and lethal sepsis. We also provided evidence that large aortic valve vegetations accompanied by severe systemic toxicity arise from high level expression of colonization factors with a slower transition towards expression of the exotoxins. Simultaneous high expression of RNAIII, sarA, sigB, and mgrA leads to severe systemic toxicity but is the one phenotype assessed in this study that fails to promote vegetation formation.
Materials and Methods
Bacterial Strains and Growth Conditions
Two sets of clinical S. aureus isolates were obtained from a French national prospective multicenter cohort, VIRSTA, that were categorized into IE or BA groups (Bouchiat et al., 2015; Le Moing et al., 2015). Patients were categorized as having definitive IE as defined by the modified Duke criteria (Li et al., 2000). Patients that presented with negative trans-thoracic or trans-esophageal echocardiograms and did not meet post-hospital criteria for IE at the 3-month follow-up visit were defined as BA (Bouchiat et al., 2015; Le Moing et al., 2015). Staphylococcal strains were used from low-passage-number stocks. All staphylococcal strains were grown in beef heart infusion broth (Bacto™ Todd Hewitt, Becton Dickinson) at 37°C with aeration (225 rpm) unless otherwise noted. Strains used in this study are listed in Table 1. For endocarditis experiments, strains were grown overnight and diluted and washed in phosphate buffered saline (PBS - 2 mM NaH2PO4, 5.7 mM Na2HPO4, 0.1 M NaCl, pH 7.4).
Table 1 Staphylococcus aureus strains tested from CC5 lineage.
Superantigen Gene Screen
Genomic DNA was extracted from single colonies grown overnight on TSAII agar plates with 5% sheep blood (Becton Dickinson) using colony lysis solution (1% Triton-X100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0) and incubating the lysate at 94°C for 15 min. Amplification was carried out using Phusion HF DNA polymerase (New England Biolabs; NEB) according to manufacturer’s instructions with superantigen-specific primers (Salgado-Pabón et al., 2014). PCR annealing temperatures were calculated using Tm Calculator v1.12.0 (NEB).
Rabbit Model of Native Valve, Left-Sided IE
The rabbit model of IE was performed as previously described (Salgado-Pabón et al., 2013). Briefly, New Zealand White Rabbits, male and female, weighing 2-3 kg were obtained from Bakkom Rabbitry (Red Wing, MN) and anesthetized with ketamine (dose range: 10-50 mg/kg) and xylazine (dose range: 2.5-10 mg/kg). Mechanical damage to the aortic valve was done by introducing a hard plastic catheter via the left carotid artery, left to pulse against the valve for 2 h, removed, and the incision closed. Rabbits were inoculated via the marginal ear vein with 1.3 – 3.6 x107 cfu in PBS and monitored 4 times daily for failure to right themselves and failure to exhibit escape behavior. Simultaneous presence of these criteria is 100% predictive of fatal outcome and represents a humane endpoint. Infection was allowed to proceed for a total of 4 days unless a humane endpoint point was reached. For pain management, rabbits received buprenorphine (dose range: 0.01 – 0.05 mg/kg) twice daily throughout the duration of the experiment. At the conclusion of each experiment, venous blood was drawn and plated onto TSA II agar plates with 5% sheep blood for bacterial counts (Becton Dickinson). Rabbits were euthanized with Euthasol (Virbac) and necropsies performed to assess overall health. Spleens were weighed, kidney pathology was graded using a gross lesion pathology scale (Table S1), aortic valves were exposed to assess vegetation growth, and vegetations that formed were excised, weighed, and suspended in PBS for bacterial counts. Gross pathology grading was developed by a board-certified veterinary pathologist specifically for this model (Gibson-Corley et al., 2013; Kinney et al., 2022) and done in a blinded manner. All experiments were performed according to established guidelines and the protocol approved by the University of Iowa Institutional Animal Care and Use Committee (Protocol 6121907). All rabbit experimental data is a result of at least 2 independent experiments per infection group.
Erythrocyte Lysis Assays for Hemolysin Production
Erythrocyte lysis assays were performed as previously described (King et al., 2016). Overnight cultures were diluted to an OD600 1.0 in PBS and 5 µl spotted onto TSA II agar plates with either 5% rabbit or sheep blood (Becton Dickinson). Plates were incubated for 24 h at 37°C with 5% CO2. Zones of hemolysis were measured and quantified using ImageJ. Data is represented by three independent experiments done with technical duplicates.
Construction of qPCR Standard Curve Template Plasmid
qPCR primers for staphylococcal superantigens and virulence factor regulators were created using the PrimerQuest Tool from Integrated DNA Technologies (IDT) (Table S2). S. aureus strains MW2, MN8, N315, and IA209 were used as template sequences. A gBlock from IDT was ordered with all S. aureus SAg and regulator target amplicons listed in Table S2. The gBlock was inserted into a BamHI linearized pUC19 vector by Gibson Assembly creating pKK81 (Gibson et al., 2009). The resultant plasmid was verified by Sanger sequencing. All qPCR standard curves were made using SacI linearized pKK81 template and diluted with IDTE pH 8.0 buffer supplemented with 0.1 mg/mL tRNA (IDT) in DNA LoBind microfuge tubes (Eppendorf). Plasmid concentration was determined using the NanoDrop™ 2000c (Thermo Fisher). Concentration was converted to template copy number by using the following equation: (C)(6.0221 x 1023 molecules/mole)/(N x 660 g/mole)(1 x 109 ng/g) = copy number/µL (IDT). C is the concentration of template in ng/µL, N is the length of the dsDNA amplicon, and 660 g/mole is the average mass of 1 bp of dsDNA.
RNA Extraction
Overnight cultures of S. aureus strains listed in Table 1 were inoculated in beef heart infusion broth at an OD600 of 0.1 and grown at 37°C with aeration (225 rpm). Isolates were collected for RNA extraction at OD600 values of 0.25-0.30 (3x108 CFU/mL), 0.80-0.85 (8x108 CFU/mL), 1.80-1.90 (18x108 CFU/mL), and 4.80-5.0 (50x108 CFU/mL). At each OD, 1x109 CFUs were pelleted by centrifugation at 16,000 x g for 30 s. Supernatants were poured off, and pellets flash frozen in liquid nitrogen and stored at -80°C for RNA extraction the next day. Bacterial pellets were resuspended in 650 µl of TRIzol (Invitrogen) and transferred to Powerbead Tubes (glass 0.1 mm) (Qiagen). Samples were placed in a FastPrep FP120 cell disrupter and run twice at full speed for 30 s with a 3-min incubation on ice between runs. An additional 350 µl of TRIzol was added to the samples and centrifuged at 16,000 x g for 60 s before being transferred to Phasemaker Tubes (Invitrogen). RNA isolation proceeded according to manufacturer’s instructions with 2 additional ethanol washes to remove any residual phenol or guanidine isothiocyanate. Contaminating gDNA was removed using the Turbo DNA-Free™ Kit (Invitrogen) with 6U of TURBO™ DNase. RNA quantity and purity were assessed using the NanoDrop™ 2000c (Thermo Fisher) with median A260/280 values of 1.93 (95% CI: 1.91-1.94) and A260/230 of 1.55 (95% CI: 1.42-1.63). RNA integrity was assessed for distinct 23s and 16s rRNA bands by non-denaturing gel electrophoresis. RNA (250 ng/sample) was added to 2X gel loading buffer II (95% formamide, 18 mM EDTA, 0.025% SDS, 0.025% xylene cyanol, and 0.025% bromophenol blue) and denatured at 95°C for 5 min followed by rapid cooling on ice for 1 min. Samples were run on a 1.2% TBE gel at 100 V (10 V/cm length between electrodes) for 1 h.
cDNA Synthesis and qPCR
cDNA synthesis was carried out using 200 ng of RNA with the High-Capacity cDNA Reverse Transcription Kit according to manufacturer’s instructions (Applied Biosystems). Each cDNA sample was diluted 1:5 (~2 ng/µL) in IDTE pH 8.0 buffer (IDT). qPCR was conducted using the 2X PrimeTime Gene Expression Master Mix (IDT) with each reaction having a final concentration of 1X PrimeTime Gene Expression Master Mix, 0.5X EvaGreen (Biotium), 500 nM forward and reverse primers (Table S2), 50 nM ROX (Thermo Scientific™), and 1 µL of the template or diluted cDNA experimental sample in a final reaction volume of 10 µL. Reactions were run under fast-qPCR conditions recommended by IDT: Activation – 95°C 3 min, 40 cycle amplification/elongation – 95°C 5 s followed by 58°C 30 s, Melt curve analysis – 95°C 5 s, 58°C 30 s, and 95°C 5 s. gDNA contamination from each sample was assessed using a total of 20 ng of RNA with reaction conditions as listed above with all samples having CT values >35. No template controls were run with each qPCR plate and had CT values >38. All qPCR reactions were run and analyzed using the standard curve quantitation method with a 10-fold dilution curve done in technical triplicates at dynamic ranges relevant for each gene (Table S3). The CT values generated from each qPCR reaction in the standard curves done in a 10-fold dilution series of 106, 105, 104, 103, 102, and 101 copy number gave CT values of ~16, 19.3, 22.6, 25.9, 29.2 and 32.5, respectively. All standard curves exhibited a R2 > 0.98, with PCR efficiencies between 90-105%, and a slope of -3.3. Melt curve analysis showed a single peak from each of the gene target amplicons. Experimental sample replicates had CT values within the standard curve with intraassay variance of 0.06-0.12 (SD of Cq) (Table S3). All plots were generated and analyzed using the QuantStudio 3 Real-Time PCR System and analysis software v1.5.1 (Applied Biosystems). Each timepoint was obtained from three biological replicates done in duplicate qPCR reactions and data represented as mean ± standard deviation (n=6).
Statistical Analyses
The Log-rank (Mantel Cox) test was used for statistical significance of survival curves. Two-way analysis of variance (ANOVA) was used to determine significance in gene expression changes throughout bacterial growth. For comparison of gene expression across mean areas under the curve (AUC), hemolytic production, spleen size, blood cfu/mL, and gross pathology grading, the one-way or two-way ANOVA with either the Holm- Šídák’s or Fisher’s LSD multiple comparisons tests were used for significance. Statistical significance of vegetation size across means was determined by one-way ANOVA Kruskal-Wallis test with uncorrected Dunn’s multiple comparison test. All statistical analyses were done using GraphPad Prism v9.3.1 software. α = 0.05.
Results
Superantigen Profile of Invasive S. Aureus CC5 Isolates
Of major importance is understanding the underlying mechanism that defines S. aureus potential for IE development and sequelae. For this purpose, we focused on S. aureus strains classified as clonal complex 5 (CC5) given their frequency in causing invasive disease in humans with severe complications, such as septic shock (Shorr et al., 2006; Wyllie et al., 2006). The invasive CC5 isolates in this study were randomly selected from a French national prospective multicenter cohort collected from patients with definitive IE (IE0560, IE1420, IE1789, IE2295) or those that did not meet the criteria for definitive infective endocarditis (IE), and hence classified as bacteremia (BA) isolates (BA0206, BA0211, BA1372, BA1791) (Li et al., 2000; Bouchiat et al., 2015; Le Moing et al., 2015). Having S. aureus isolates from endocarditis and bacteremia patients allows us to assess how intrinsic bacterial characteristics of invasive isolates correlate with IE development and/or disease severity, as tested in a rabbit model of left-sided, native valve IE.
Superantigens are critically important for S. aureus IE development and strains deficient in these virulence factors are significantly attenuated in experimental IE (Salgado-Pabón et al., 2013; Stach et al., 2016; Kinney et al., 2022). Given the contribution of superantigens to IE but knowing that they are variably encoded (Nienaber et al., 2011), we performed a genomic screen for the presence of 22 superantigens. selX and the enterotoxin gene cluster (egc) superantigens seg, sei, sem, sen, seo, and selu were detected in all 8 isolates (Table 1). entC (SEC gene) and tstH (TSST1 gene) were detected in only 2 of the isolates, both of IE origin. entD (SED gene), sej, ser, sep, and sel were variably present across isolates. sea, entB (SEB gene), entE (SEE gene), seh, sek, seq, ses, and set were not detected in any of the S. aureus isolates. Therefore, we confirmed that at minimum all the isolates encoded the egc superantigens, shown to be sufficient for IE development (Stach et al., 2016). Hence, all 8 strains have the potential to cause IE.
Invasive S. Aureus CC5 Isolates Vary in Causation of IE and Lethal Sepsis
To establish the clinical manifestations of invasive S. aureus CC5 isolates in experimental IE, New Zealand White rabbits were injected intravenously with 1.3 – 3.6 x107 cfu, after 2 h mechanical damage to the aortic valve. Rabbits were monitored for up to 4 days. During that period, 5 isolates (BA0206, BA1791, IE0560, IE1420, and IE2295) formed similarly sized vegetations with median ranges of 20–32 mg (Figure 1A). The largest vegetations were observed in BA0211 (median 82 mg) and IE1789 (median 94.5 mg) (Figure 1A). The notable exception was BA1372, which was deficient in promoting IE with a vegetation median of 9.5 mg (Figure 1A). As with vegetation formation, significant differences in lethality were directly related to individual strains. Most isolates (7/8) exhibited high lethality with less than 50% of rabbits surviving the infection (Figures 1B–E). BA0206 and BA0211 were the most lethal with 100% of rabbits succumbing to the disease (Figure 1B). In stark contrast, infection with IE1789 resulted in 83% survival during the experimental period despite being one of the strains producing the largest vegetations (Figures 1A, E). Also of note is BA1372, which exhibited 50% lethality in spite of its deficiency in vegetation formation (Figures 1A, C).
Figure 1 Differential development of infective endocarditis and lethality in S. aureus CC5 strains. Rabbit model of native valve IE and sepsis. Rabbits were injected intravenously with 1.3–3.6 x 107 CFUs of S. aureus CC5 isolates after mechanical damage of aortic valve and monitored over 4 days. (A) Total weight of vegetations dissected from aortic valves. *, p < 0.05, **, p < 0.005, ****, p < 0.0001, one-way ANOVA, non-parametric Kruskal-Wallis with uncorrected Dunn’s multiple comparison test to BA1372 (IE-deficient). Bars represent mean value. (B–E) Percent survival. (B) BA0206 and BA0211. (C) BA1372 and BAA1791. (D) IE0560 and IE1420. (E) IE1789 and IE2295. p < 0.03, Log-rank (Mantel-Cox) of IE1789 compared to each strain.
S. aureus IE is commonly characterized by hematogenous spread with establishment of metastatic infections and systemic pathology (Tong et al., 2015). These complications also occur in our rabbit model and present as acute kidney injury, ischemic liver lesions, and lung injury. In this study, rabbits (n=55) were grossly assessed and scored for the presence of kidney lesion pathology on a scale from 0-3. Lesions in the S. aureus IE rabbit model present as hemorrhagic, necrotic, or ischemic (Figure 2A). In the most severe pathology (grade 3), lesions are locally extensive, coalescing to diffuse, and extend across a large surface of the kidney (Table S1). Infection with S. aureus CC5 isolates led to severe pathology in >50% of rabbits (Figure 2B). The severity of acute kidney injury was consistent with lethality exhibited by individual strains. BA0206 and BA0211 (strains with the highest lethality) induced grade 3 pathology in 100% of rabbits, while IE1789 (strain with the highest survival) induced no lesions or grade 1 pathology in >75% of rabbits (Figure 2B). S. aureus isolates were recovered from the bloodstream at endpoints in the range of 1 x103 – 1.3 x105 cfu/mL (Figure 2C), with the sole exception being IE1789 where fewer than 100 bacteria were detected in the bloodstream in 5/6 rabbits (Figure 2C). The data indicates that most (5/8) strains have common characteristics that drive IE development and systemic complications to similar extent. However, it is also evident that individual strain characteristics determine the severity of the disease.
Figure 2 Acute kidney injury and bacteremia resulting from S. aureus CC5 IE. Rabbit model of native valve IE and sepsis. Rabbits were injected intravenously with 1.3–3.6 x 107 cfu of S. aureus CC5 isolates after mechanical damage of aortic valve and monitored over 4 days. (A) Kidney gross pathology grading scale (grades 0-3). 0 = no lesions, 1 = rare, small (<4mm) multifocal lesions, 2 = numerous large (>5mm) multifocal lesions, 3 = extensive to coalescing to diffuse lesions. Arrows indicate ischemic and/or hemorrhagic lesions, arrowhead indicates a necrotic lesion. (B) Scoring of kidney lesions post-mortem. One-way ANOVA with Fisher’s LSD multiple comparisons test across strains. p < 0.002, IE1789 compared to the rest of the strains. (C) Bacterial counts per milliliter of blood recovered from rabbits post-mortem. Lines represent median value. *, p < 0.02, one-way ANOVA Kruskal-Wallis test with uncorrected Dunn’s multiple comparison test across strains.
Extensive phenotypic variation among clinical isolates is a growing subject in medical microbiology (Jelsbak et al., 2010). In S. aureus, major strain-dependent differences in gene expression are in part caused by differential expression of global regulators and two-component systems (Jelsbak et al., 2010; Zhao et al., 2019). RNAIII, rot, sarA, sarS, sigB, and mgrA have previously been shown to influence expression of S. aureus virulence factors (Schmidt et al., 2004; Ingavale et al., 2005; Tseng and Stewart, 2005; Andrey et al., 2010; Kusch et al., 2011; Andrey et al., 2015; Tuffs et al., 2019). Hence, we addressed their gene expression in our strain collection next.
Differential Expression of RNAIII and Rot in CC5 Strains
RNAIII is a regulatory RNA and effector molecule of the Agr quorum-sensing system that differentially controls expression of S. aureus surface proteins [e.g. microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) and protein A] and the secreted toxins and enzymes (e.g. hemolysins, superantigens, proteases, nucleases, lipases) (Jenul and Horswill, 2019). RNAIII expression itself is regulated by the Agr system. When the Agr system is active, RNAIII is expressed which in turn represses surface proteins and induces exoproteins. The opposite is also true. RNAIII control of exoprotein production is achieved indirectly via translational suppression of the global regulator Rot (Mcnamara et al., 2000; Geisinger et al., 2006). Rot (for repressor of toxins) inhibits transcription of toxins and extracellular proteases during growth in exponential phase, when the Agr system is inactive and RNAIII is uninduced, while at the same time induces production of ClfA, coagulase, protein A, and the transcriptional regulator SarS (Saïd-Salim et al., 2003) (Figure S1).
Traditionally, comparative CT quantitation is performed for studies of gene expression. The biggest challenge with this method is comparing and interpreting relative expression data between studies that use non-isogenic strains or strains with phenotypic plasticity, as deviations in expression of the housekeeping gene(s) of choice changes the results (Pfaffl, 2004; Huggett et al., 2005; Valihrach and Demnerova, 2012). This is the case for the S. aureus CC5 collection. Absolute RT-qPCR analysis using the standard curve method is a well-established gene expression analysis designed to not rely on the expression of housekeeping genes, which need to be validated for every strain in every growth condition and growth state (Mazza and Mazzette, 2014; Lee et al., 2006). We quantified absolute copies of the gyrB transcript, a common S. aureus housekeeping gene (Valihrach and Demnerova, 2012; Sihto et al., 2014; Crosby et al., 2016; Stach et al., 2016), by RT-qPCR using the standard curve method (Figure S2) (Bustin, 2000; Pfaffl, 2004). For this purpose, S. aureus isolates were grown to specific cell densities for a period of 6 h in TH (beef heart infusion) broth. Growth in exponential phase (2.8 – 18 x108 cfu/mL) resulted in stable gyrB expression (ΔCT < 0.5) in 7 out of 8 isolates. IE2295 was the only strain with a 2-fold decrease in gyrB expression (ΔCT > 0.5) during exponential growth (Figure S2B). Yet, gyrB expression was not stable during growth in stationary phase (18 – 50 x108 cfu/mL) with half the strains exhibiting 2-fold decreases that could potentially affect experimental outcomes (Figure S2) (Bustin, 2000; Pfaffl, 2004; Huggett et al., 2005; Valihrach and Demnerova, 2012). In lieu of validating 3-4 other housekeeping genes to accurately perform our studies, we favored the use of absolute RT-qPCR analysis as a method better suited to address the dynamics of gene expression during growth and to assess the abundance of multiple transcripts of interest within a strain at different growth states and across multiple strains.
In our S. aureus CC5 collection of invasive isolates, RNAIII expression increased 10 – 3000-fold from early to post-exponential growth in 7 out 8 of strains (Figures 3A, B). IE1789 and IE2295 started with less than 1000 copies/ng of RNAIII, but while in IE2295 RNAIII expression was rapidly induced to more than a million copies/ng, RNAIII expression in IE1789 remained low and uninduced (Figure 3B). BA0206 and IE0560 started with the highest RNAIII levels but only expression in BA0206 continued to increase through growth in stationary phase (Figures 3A, B) resulting in the strain having the highest RNAIII levels in the collection (Figure 3C). Three other strains also exhibited significantly higher levels of RNAIII, BA1372, BA1791, and IE2295 (Figure 3C). BA0211 and IE1420 were unique in that RNAIII expression significantly increased during post-exponential growth reaching close to top-level expression at 50 x108 cfu/mL (Figures 3A, B).
Figure 3 RNAIII and rot expression in S. aureus CC5 isolates. Quantitation of S. aureus CC5 gene expression during growth in TH broth by RT-qPCR standard curve quantitation method. (A, B) RNAIII expression and (D, E) rot expression at indicated cell densities. Error bars (standard deviation) not shown are smaller than symbol. Asterisks indicate data points significantly different than the rest at that specific cell density. (C, F) Area under the curve (mean ± SEM). Data is the result of three biological replicates. *, p < 0.05, **, p < 0.005, ***, p < 0.0005, ****, p < 0.0001, one-way ANOVA with Holm-Šídák’s multiple comparisons test across strains.
Rot expression was inversely proportional to RNAIII expression, peaking at 8 – 18 x108 cfu/mL (Figures 3D–F). In most strains, rot expression decreased during post-exponential growth concomitant to RNAIII expression (Figures 3D, E). IE1789 (the lowest RNAIII expressor) expressed rot at high levels while BA0206 (the highest RNAIII expressor) exhibited low and uninduced rot expression (Figures 3D, F). Given that expression of most S. aureus hemolysins is controlled by RNAIII and Rot, we tested the hemolytic activity of the CC5 isolates against both rabbit and sheep erythrocytes. As expected, IE1789 was non-hemolytic against rabbit erythrocytes (Figure 4A) and showed very low hemolytic activity against sheep erythrocytes (Figure 4B). The rest of the strains exhibited hemolytic activity consistent with expression of hemolysins such as α-toxin, β-toxin, and phenol-soluble modulins (PSMs) (Figure 4). From these results, it becomes evident that RNAIII expression is not a critical requirement for S. aureus vegetation formation, as exemplified by strains IE1789 (proficient) and BA1372 (deficient).
Figure 4 Hemolytic activity in S. aureus CC5 isolates. Overnight cultures of S. aureus CC5 isolates were washed and spotted onto (A) 5% rabbit blood and (B) 5% sheep blood TSA II agar plates. Zones of hemolysis were measured after overnight growth. (Top) Representative images of hemolytic activity in strains IE1789 and BA1372. (Bottom) Relative levels of hemolysin production as measured in an erythrocyte lysis assay. Data are represented as mean ± SEM. *, p < 0.05, **, p < 0.005, ***, p < 0.0005, ****, p < 0.0001, one-way ANOVA with Holm-Šídák’s multiple comparisons test to the non-hemolytic strain IE1789.
Differential Expression of sarA and sarS in CC5 Strains
SarA is known to increase expression of the agr system (Heinrichs et al., 1996; Rechtin et al., 1999; Jenul and Horswill, 2019) and to repress expression of the transcriptional regulators sarS and rot (Cheung et al., 2001; Hsieh et al., 2008) and genes encoding for protein A and proteases (Morrison et al., 2012). SarS acts opposite to SarA by inducing spa (Protein A) gene expression and repressing expression of several toxin genes such as hla (α-toxin gene) (Figure S1) (Tegmark et al., 2000). sarA expression patterns were more diverse among the S. aureus CC5 isolates. During exponential growth, sarA was significantly induced in strains BA206 and IE0560, while repressed in IE1789 (Figures 5A, B). During post-exponential growth, sarA was significantly induced in BA1372, while repressed in BA1791, IE0560, and IE1420 (Figures 5A, B). BA0211 was the only strain that did not exhibit significant sarA induction throughout growth (Figures 5A, B). Overall, BA1372, IE0560, and IE2295 exhibited the highest sarA levels (Figure 5C). Consistent with the literature, sarA expression was inversely proportional to sarS (Figures 5D–F). The sole exception being BA206, which exhibited low and uninduced expression of sarS, not concomitant with sarA expression (Figure 5D) but consistent with low and uninduced rot (Figure 2D). Significantly higher levels of sarS were seen in BA0211, BA1791, IE1420, and IE1789 (Figure 5F). These strains also exhibited higher levels of rot, a positive regulator of sarS expression (Figure 2F) (Saïd-Salim et al., 2003). No requirement was evident for sarA induction in vegetation formation, as exemplified by strains BA0211 and IE1789.
Figure 5 sarA and sarS expression in S. aureus CC5 isolates. Figure 3. Quantitation of S. aureus CC5 gene expression during growth in TH broth by RT-qPCR standard curve quantitation method. (A, B) sarA expression and (D, E) sarS expression at indicated cell densities. Error bars (standard deviation) not shown are smaller than symbol. Asterisks indicate data points significantly different than the rest at a specific cell density. (C, F) Area under the curve (mean ± SEM). Data is the result of three biological replicates. *, p < 0.05, **, p < 0.005, ***, p < 0.0005, one-way ANOVA with Holm-Šídák’s multiple comparisons test across strains.
Differential Expression of sigB and mgrA in CC5 Strains
The alternative sigma factor B (SigB) controls hundreds of genes, many of which are involved in stress responses as well as virulence (Guldimann et al., 2016). SigB directly inhibits expression of the agr operon (Bischoff et al., 2001), but induces expression of sarA, adhesin genes (e.g ClfA and FnBPs genes), and the egc superantigen operon (Bischoff et al., 2004; Entenza et al., 2005; Kusch et al., 2011). SigB is also reported to represses expression of rot specifically during growth in stationary phase (Figure S1) (Hsieh et al., 2008). In our collection of invasive S. aureus strains, sigB expression peaked early at 8 x108 cfu/mL but was followed by a rapid drop in expression with further growth (Figures 6A, B). Of the isolates with the highest sigB expression (Figure 6C), BA0206, BA0211, and BA1372 achieved it by maintaining expression in post-exponential growth (Figure 6A), while IE1420 and IE1789 achieved it by inducing it at high levels in exponential phase (Figure 6B). It was of interest to establish whether the temporal expression of sigB in high-expressing isolates could result in differential gene expression of sigB-regulated genes important for IE development. For that purpose, we tested BA1372 (IE deficient) and IE1789 (IE proficient) for expression of the egc operon, which promotes vegetation formation and is induced by SigB (Kusch et al., 2011; Stach et al., 2016). In IE1789, egc expression was highest during exponential growth (Figure 7A) whereas in BA1372 egc expression remained low throughout (Figure 7B). Consistent with SigB induction of egc superantigens specifically, expression of selX (reported to be under saeRS control) was almost identical in both strains (Figures 7A, B) (Langley et al., 2017). Hence, temporal expression of master regulators contributes to the phenotypic heterogeneity of S. aureus strains and possibly variable disease outcomes.
Figure 6 sigB and mgrA expression in S. aureus CC5 isolates. Quantitation of S. aureus CC5 gene expression during growth in TH broth by RT-qPCR standard curve quantitation method. (A, B) sigB expression and (D, E) mgrA expression at indicated cell densities. Error bars (standard deviation) not shown are smaller than symbol. Asterisks indicate data points significantly different than the rest at a specific cell density. (C, F) Area under the curve (mean ± SEM). Data is the result of three biological replicates. *, p < 0.05, **, p < 0.005, ***, p < 0.0005, one-way ANOVA with Holm-Šídák’s multiple comparisons test across strains.
Figure 7 Differential expression of egc SAgs and selx. Quantitation of egc mRNA in S. aureus CC5 during growth in TH broth by RT-qPCR standard curve quantitation method. egc and selx expression in (A) IE1789 and (B) BA1372 at indicated cell densities. Error bars (standard deviation) not shown are smaller than symbol. Data is the result of three biological replicates. Two-way ANOVA with Holm-Šídák’s multiple comparisons test across superantigen pairs in IE1789 and BA1372 during exponential growth.
MgrA regulatory effects mirror those of the agr system, as RNAIII stabilizes mgrA when derived from the P2 promoter, although the specific targets can be distinct (Luong et al., 2006; Gupta et al., 2015). It has also been reported that MgrA regulates agr expression in some strains (Jenul and Horswill, 2019). MgrA upregulates production of secreted proteins (e.g. leukotoxins, Spl proteases, enzymes) and downregulates production of surface-associated proteins (e.g. large surface protein Ebh, SraP, SasG; Figure S1) (Luong et al., 2006; Crosby et al., 2016). Initial mgrA levels in our S. aureus CC5 collection ranged from 10,000 – 40,000 copies/ng and remained stable and at its highest throughout exponential growth (Figures 6D, E). Once in post-exponential growth, mgrA expression significantly decreased in all strains. The one exception was IE2295 which exhibited a significant decrease in mgrA expression during exponential growth (Figure 6E). Half the strains expressed mgrA at significantly higher levels with a more distinct separation of high versus low expressors within the endocarditis isolates (Figure 6F).
Inverse Correlation Between RNAIII and sarA Expression and Vegetation Formation in S. Aureus CC5 Strains
A remaining question is, what drives differential vegetation formation in these isolates? To address this question, we performed a Pearson correlation analysis of gene expression among the six global regulators examined in this study and median vegetation size produced by the eight S. aureus CC5 isolates. Consistent with the literature, RNAIII expression inversely correlated with rot, and rot expression directly correlated with sarS in all isolates (Figure 8A). sarA expression inversely correlated with sarS and rot in 7/8 isolates (exception BA0206; Figure 8B). In 6/8 strains, sigB expression inversely correlated with sarA (exceptions BA1372 and BA1791) and inversely correlated with RNAIII (exceptions BA1372, BA0206), and therefore lacked statistical significance (Figure 8C and data not shown). The inverse correlation between sigB and sarA expression in most of the CC5 isolates in our collection was surprising given that SigB is reported to upregulate SarA (Manna et al., 1998). There was no correlation between RNAIII and mgrA (Figure 8C) or RNAIII and sigB were not correlated in the studied strains (). Of great interest, vegetation size inversely correlated with both RNAIII expression and sarA expression, with a stronger correlation observed with RNAIII (Figure 8D). It was intriguing that BA0206 produced large vegetations despite having the highest RNAIII expression, in particular when BA1372 was deficient in vegetation formation. In this strain high RNAIII expression was accompanied by concomitant low sarA, sarS, rot and mgrA expression (Figures 8B, C) and unconventionally by high sigB expression (Figure 8C). BA1372 RNAIII expression was instead accompanied by concomitant high sarA, sigB and mgrA expression (Figures 8C, D). Altogether, the combination of high expression of RNAIII, sarA, sigB, and mgrA was unique to BA1372 in our collection, while the combination of high RNAIII and sigB with low sarA and mgrA was unique to BA0206. Overall, these results highlight the heterogeneity among the CC5 lineage but reveals expression patterns specific to IE deficient and proficient strains.
Figure 8 Vegetation formation inversely correlates with RNAIII and sarA expression in S. aureus CC5 isolates. (A) Expression correlation between RNAIII and rot (top panel) or rot and sarS (bottom panel). (B) Expression correlation between sarA and sarS (top panel) or sarA and rot (bottom panel). (C) Expression correlation between sigB and sarA (top panel) or RNAIII and mgrA (bottom panel). (D) Correlation between vegetation size and RNAIII expression (top panel) or sarA expression (bottom panel). Pearson correlation coefficients (Pearson r), correlation p value, and best-fit line shown. Expression correlation between RNAIII and sigB is not shown; Pearson r = -0.34 (p = 0.5).
Discussion
S. aureus CC5 isolates are prevalent colonizers and agents of infection in the U.S. and have become a predominant IE clonal group (Enright et al., 2002; Tenover et al., 2008; Limbago et al., 2009; Roberts, 2013). However, it has been long recognized that S. aureus exists as a heterogenous population showing extensive phenotypic variation with regulation of single genes that can vary considerably even within clonal groups (Jelsbak et al., 2010). Regulation of virulence factors results from a complex network of host and environmental cues that elicit a coordinated response. Changes in the levels of major components of these regulatory networks affects how S. aureus responds to a given cue. In the present study, we investigated the dynamic expression of prominent global regulators of virulence in eight invasive S. aureus CC5 isolates and established intrinsic expression patterns associated with IE outcomes. RNAIII [agr], rot, sarS, sarA, sigB, and mgrA are regulators important for the transition from a colonization state to an invasive, toxin-producing state (Jenul and Horswill, 2019). We provide evidence that vegetation formation, as tested in the rabbit model of left-sided native valve IE, inversely correlates with RNAIII and sarA expression when grown in beef heart infusion broth. Of interest, even with a small collection of isolates from the same clonal group, 4 distinct clinical outcomes were observed: (i) strains with similar vegetation size, kidney injury, and lethality (BA1791, IE0560, IE1420, and IE2295), (ii) a strain that produces average-size vegetations but causes more severe kidney injury with increased lethality (BA0206), (iii) strains that produce significantly larger vegetations but differ in potential to cause kidney injury and lethal sepsis (IE1789 and BA0211), and (iv) a strain that is deficient in vegetation formation but proficient in causing kidney injury and lethal sepsis (BA1372).
Based on the correlation analysis, one would have expected BA0206 to be less efficient at promoting IE, as it exhibits the highest RNAIII expression concomitant with basal levels of rot and sarS transcript. Yet, BA0206 is one of five strains that are similar in their ability to promote vegetation formation. Furthermore, infection with BA0206 results in dissemination, systemic toxicity, and lethality indistinguishable from that of BA0211 (strain that produces exceptionally large vegetations and lethal sepsis). While RNAIII expression is high, this is not reflected in its hemolytic activity against both rabbit and sheep erythrocytes, which together are sensitive to the action of the pore-forming toxins, phenol-soluble modulins, and the sphingomyelinase β-toxin. The lower sarA expression levels in this strain may help counter-balance high expression of RNAIII. Low SarA increases expression of proteases that degrade extracellular virulence factors, which can help explain the lower hemolytic activity (Zielinska et al., 2012). High sigB expression (surprising for a strain with high RNAIII expression) can induce production of colonization factors required for vegetation formation.
IE1789 and BA0211 are highly proficient in forming large aortic valve vegetations yet induce drastically divergent systemic outcomes. IE1789 has no inducible expression of RNAIII, resulting in no or minimal hemolysis. High expression of rot, sarS, and sigB indicates that IE1789 is locked in a colonization state as these regulators are known to induce production of MSCRAMMs (e.g. clumping factors, fibronectin-binding proteins, protein A), enzymes (e.g. coagulase), and the egc superantigens. Many of these virulence factors have been shown to contribute to development of S. aureus IE in experimental models (Vernachio et al., 2003; Que et al., 2005; Malachowa et al., 2011; McAdow et al., 2011; Stach et al., 2016). These results provide further evidence that the Agr-regulated exoproteins (at minimum the pore-forming toxins) are not critical for establishing S. aureus IE and provide insights into the minimal requirements for vegetation formation on native valves. Similar observations have been reported with S. aureus agr mutants tested in a catheter-associated IE model (Cheung et al., 1994; Seidl et al., 2011). Yet, with a deficient Agr system, IE1789 virulence is severely diminished. Heart valve infection fails to promote dissemination and acute kidney injury, resulting in most of the rabbits surviving the experimental period in spite of the presence of large vegetations. Without the RNAIII-regulated exoproteins, S. aureus native valve IE resembles that of the oral pathogen Streptococcus sanguinis, characterized by subacute, chronic thrombosis with low systemic toxicity and low lethality (Martini et al., 2020).
In stark contrast, BA0211 IE leads to metastatic infection, the most severe kidney injury, and lethality in all experimental rabbits. RNAIII expression occurs at a slower rate resulting in overall low expression with concomitant high rot and sarS expression. In BA0211, sarA expression is not only low but also uninduced throughout growth, partially explaining the lower RNAIII levels observed in this strain and decreased cytotoxicity towards rabbit erythrocytes. The expression patterns of the global regulators in this strain suggest that large aortic valve vegetations accompanied by severe systemic toxicity arise from strains that express colonization factors at high level but have a slower transition towards expression of the secreted virulence factors. Overall, we cannot exclude the possibility that other regulatory elements are responsible for the clinical outcomes of the S. aureus CC5 isolates tested in our model.
Why the use of absolute RNA quantification for the temporal expression analysis of genes in our study? RT-qPCR comparative CT method is commonly used to study the regulation and function of genes. Nevertheless, fold changes do not provide sufficient insight into the abundance of the transcripts of interest, making it difficult to interpret the differences between genes within and across strains. For example, a 4-fold increase in expression calculated by the comparative CT method may represent mRNA copy number changes from 10 to 40 or 100,000 to 400,000. This is especially pertinent in organisms like S. aureus that exhibit high heterogeneity in virulence factor production that can subsequently influence disease pathogenesis and virulence. The RT-qPCR normalization method described here provides accurate analysis of gene expression data in S. aureus. This allows comparisons to be made across S. aureus studies and provides tools to establish the relative importance of S. aureus virulence factors in pathogenesis.
We acknowledge that expression can vary between in vitro and in vivo settings. The strength of our study design is in that it explores the intrinsic phenotypic differences of eight invasive isolates in promoting vegetation formation as tested in the rabbit model of IE. The animal study provided evidence that there is something uniquely different about specific strains. Growth in beef heart infusion broth allows us to quantify and define expression patterns of key regulators of virulence in all eight strains throughout growth. The ability to test gene expression at specific cell densities is critically important in S. aureus given the regulatory control of colonization factors and secreted virulence factors by quorum sensing. In follow-up studies, we will perform RNAseq analysis of bacteria present in vegetations to gain insights into the in vivo gene expression profile of S. aureus during IE. Because expression studies are done on strains following observations of their phenotypes in experimental IE, it is not feasible to perform the analysis in a large strain collection, which is a limitation in our study. We are poised to address this in future studies.
In conclusion, this study highlights the requirement of a more measured expression of RNAIII and sarA as an intrinsic phenotypic characteristic of strains proficient in development of IE with severe complications. Simultaneous high expression of RNAIII, sarA, sigB, and mgrA leads to severe systemic toxicity but is the one phenotype that fails to promote vegetation formation in the native valve model. Thus, RNAIII and sarA expression that provides for rheostat control of colonization and virulence genes, rather than an on and off switch, promote both vegetation formation and lethal sepsis.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Author Contributions
Conceptualization, KJK and WS-P. Methodology, KJK, and WS-P. Formal Analysis, KJK and WS-P. Investigation, KJK, JS, KK, and MB, and WS-P. Writing – original draft, KJK and WS-P. Writing – review & editing, KJK, JS, KK, and MB, and WS-P. Visualization, KJK, and WS-P. Supervision, WS-P. Funding Acquisition, WS-P. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by National Institutes of Health (NIH) grant R01AI34692-01 to WS-P, NIH grant T32GM008365 to KK, and NIH grant T32AI007260-20 to JS.
Conflict of Interest
KK is currently an employee of Integrated DNA Technologies, which sells reagents used or like those used in this manuscript.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
We thank Katherine N. Gibson-Corley, DVM, Ph.D., Dipl. ACVP for providing gross pathology expertise, and François Vandenesch, M.D., Ph.D. for providing the S. aureus CC5 isolates.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2022.925914/full#supplementary-material
References
Andrey, D. O., Jousselin, A., Villanueva, M., Renzoni, A., Monod, A., Barras, C., et al. (2015). Impact of the Regulators SigB, Rot, SarA and SarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus Aureus. PloS One 10, e0135579–e0135579. doi: 10.1371/journal.pone.0135579
Andrey, D. O., Renzoni, A., Monod, A., Lew, D. P., Cheung, A. L., Kelley, W. L. (2010). Control of the Staphylococcus Aureus Toxic Shock Tst Promoter by the Global Regulator SarA. J. Bacteriol. 192, 6077–6085. doi: 10.1128/JB.00146-10
Bastien, S., Meyers, S., Salgado-Pabón, W., Giulieri, S., Rasigade, J.-P., Liesenborghs, L., et al. (2022). All Staphylococcus Aureus Bacteraemia Strains Have the Potential to Cause Infective Endocarditis: Results of GWAS and Experimental Animal Studies. bioRxiv. doi: 10.1101/2022.05.16.491111
Bergin, S. P., Holland, T. L., Fowler, V. G., Tong, S. Y. C. (2017). “Bacteremia, Sepsis, and Infective Endocarditis Associated With Staphylococcus Aureus,” in Current Topics in Microbiology and Immunology. Eds. Bagnoli, F., Rappuoli, R., Grandi, G. (Cham: Springer International Publishing), 263–296. doi: 10.1007/82_2015_5001
Bertling, A., Niemann, S., Hussain, M., Holbrook, L., Stanley, R. G., Brodde, M. F., et al. (2012). Staphylococcal Extracellular Adherence Protein Induces Platelet Activation by Stimulation of Thiol Isomerases. Arterioscler. Thromb. Vasc. Biol. 32, 1979–1990. doi: 10.1161/ATVBAHA.112.246249
Bischoff, M., Dunman, P., Kormanec, J., Macapagal, D., Murphy, E., Mounts, W., et al. (2004). Microarray-Based Analysis of the Staphylococcus Aureus ςb Regulon. J. Bacteriol. 186, 4085–4099. doi: 10.1128/JB.186.13.4085-4099.2004
Bischoff, M., Entenza, J. M., Giachino, P. (2001). Influence of a Functional sigB Operon on the Global Regulators Sar and Agr in Staphylococcus Aureus. J. Bacteriol. 183, 5171–5179. doi: 10.1128/JB.183.17.5171-5179.2001
Boucher, H., Miller, L. G., Razonable, R. R. (2010). Serious Infections Caused by Methicillin-Resistant Staphylococcus Aureus. Clin. Infect. Dis. 51, S183–S197. doi: 10.1086/653519
Bouchiat, C., Moreau, K., Devillard, S., Rasigade, J.-P., Mosnier, A., Geissmann, T., et al. (2015). Staphylococcus Aureus Infective Endocarditis Versus Bacteremia Strains: Subtle Genetic Differences at Stake. Infect. Genet. Evol. 36, 524–530. doi: 10.1016/j.meegid.2015.08.029
Bustin, S. A. (2000). Absolute Quantification of Mrna Using Real-Time Reverse Transcription Polymerase Chain Reaction Assays. J. Mol. Endocrinol. 25, 169–193. doi: 10.1677/jme.0.0250169
Challagundla, L., Reyes, J., Rafiqullah, I., Sordelli, D. O., Echaniz-Aviles, G., Velazquez-Meza, M. E., et al. (2018). Phylogenomic Classification and the Evolution of Clonal Complex 5 Methicillin-Resistant Staphylococcus Aureus in the Western Hemisphere. Front. Microbiol. 9, 1901. doi: 10.3389/fmicb.2018.01901
Cheung, A. L., Eberhardt, K. J., Chung, E., Yeaman, M. R., Sullam, P. M., Ramos, M., et al. (1994). Diminished Virulence of a Sar-/Agr- Mutant of Staphylococcus Aureus in the Rabbit Model of Endocarditis. J. Clin. Invest. 94, 1815–1822. doi: 10.1172/JCI117530
Cheung, A. L., Schmidt, K., Bateman, B., Manna, A. C. (2001). SarS, a SarA Homolog Repressible by Agr, is an Activator of Protein a Synthesis in Staphylococcus Aureus. Infect. Immun. 69, 2448–2455. doi: 10.1128/IAI.69.4.2448-2455.2001
Crosby, H. A., Schlievert, P. M., Merriman, J. A., King, J. M., Salgado-Pabón, W., Horswill, A. R. (2016). The Staphylococcus Aureus Global Regulator MgrA Modulates Clumping and Virulence by Controlling Surface Protein Expression. PloS Pathog. 12, e1005604. doi: 10.1371/journal.ppat.1005604
Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., Spratt, B. G. (2002). The Evolutionary History of Methicillin-Resistant Staphylococcus Aureus (MRSA). Proc. Natl. Acad. Sci. U. S. A. 99, 7687–7692. doi: 10.1073/pnas.122108599
Entenza, J. M., Moreillon, P., Senn, M. M., Kormanec, J., Dunman, P. M., Berger-Bächi, B., et al. (2005). Role of ςb in the Expression of Staphylococcus Aureus Cell Wall Adhesins ClfA and FnbA and Contribution to Infectivity in a Rat Model of Experimental Endocarditis. Infect. Immun. 73, 990–998. doi: 10.1128/IAI.73.2.990-998.2005
Fechter, P., Caldelari, I., Lioliou, E., Romby, P. (2014). Novel Aspects of RNA Regulation in Staphylococcus Aureus. FEBS Lett. 588, 2523–2529. doi: 10.1016/j.febslet.2014.05.037
Fernández-Hidalgo, N., Almirante, B., Tornos, P., González-Alujas, M. T., Planes, A. M., Galiñanes, M., et al. (2012). Immediate and Long-Term Outcome of Left-Sided Infective Endocarditis. A 12-Year Prospective Study From a Contemporary Cohort in a Referral Hospital. Clin. Microbiol. Infect. 18, E522–E530. doi: 10.1111/1469-0691.12033
Fernández-Hidalgo, N., Ribera, A., Larrosa, M. N., Viedma, E., Origüen, J., de Alarcón, A., et al. (2018). Impact of Staphylococcus Aureus Phenotype and Genotype on the Clinical Characteristics and Outcome of Infective Endocarditis. A Multicentre, Longitudinal, Prospective, Observational Study. Clin. Microbiol. Infect. 24, 985–991. doi: 10.1016/j.cmi.2017.12.002
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., et al. (2005). Staphylococcus Aureus Endocarditis: A Consequence of Medical Progress. J. Am. Med. Assoc. 293, 3012–3021. doi: 10.1001/jama.293.24.3012
Geisinger, E., Adhikari, R. P., Jin, R., Ross, H. F., Novick, R. P. (2006). Inhibition of Rot Translation by RNAIII, a Key Feature of Agr Function. Mol. Microbiol. 61, 1038–1048. doi: 10.1111/j.1365-2958.2006.05292.x
Gibson-Corley, K. N., Olivier, A. K., Meyerholz, D. K. (2013). Principles for Valid Histopathologic Scoring in Research. Vet. Pathol. 50, 1007–1015. doi: 10.1177/0300985813485099
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, III, C. A., Smith, H. O. (2009). Enzymatic Assembly of DNA Molecules Up to Several Hundred Kilobases. Nat. Methods 6, 343. doi: 10.1038/nmeth.1318
Grundstad, M. L., Parlet, C. P., Kwiecinski, J. M., Kavanaugh, J. S., Crosby, H. A., Cho, Y.-S., et al. (2019). Quorum Sensing, Virulence, and Antibiotic Resistance of USA100 Methicillin-Resistant Staphylococcus Aureus Isolates. mSphere 4, e00553–e00519. doi: 10.1128/msphere.00553-19
Guldimann, C., Boor, K. J., Wiedmann, M., Guariglia-Oropeza, V. (2016). Resilience in the Face of Uncertainty: Sigma Factor B Fine-Tunes Gene Expression to Support Homeostasis in Gram-Positive Bacteria. Appl. Environ. Microbiol. 82, 4456–4469. doi: 10.1128/AEM.00714-16
Gupta, R., Luong, T. T., Lee, C. Y. (2015). RNAIII of the Staphylococcus Aureus Agr System Activates Global Regulator MgrA by Stabilizing mRNA. Proc. Natl. Acad. Sci. U. S. A. 112, 14036–14041. doi: 10.1073/pnas.1509251112
Heinrichs, J. H., Bayer, M. G., Cheung, A. L. (1996). Characterization of the Sar Locus and its Interaction With Agr in Staphylococcus Aureus. J. Bacteriol. 178, 418–423. doi: 10.1128/jb.178.2.418-423.1996
Heying, R., van de Gevel, J., Que, Y. A., Moreillon, P., Beekhuizen, H. (2007). Fibronectin-Binding Proteins and Clumping Factor A in Staphyococcus Aureus Experimental Endocarditis: FnBPA is Sufficient to Active Human Endothelial Cells. Thromb. Haemost. 97, 617–626. doi: 10.1160/TH06-11-0640
Hsieh, H. Y., Ching, W. T., Stewart, G. C. (2008). Regulation of Rot Expression in Staphylococcus Aureus. J. Bacteriol. 190, 546–554. doi: 10.1128/JB.00536-07
Huggett, J., Dheda, K., Bustin, S., Zumla, A. (2005). Real-Time RT-PCR Normalisation; Strategies and Considerations. Genes Immun. 6, 279–284. doi: 10.1038/sj.gene.6364190
Ingavale, S., Van Wamel, W., Luong, T. T., Lee, C. Y., Cheung, A. L. (2005). Rat/MgrA, a Regulator of Autolysis, is a Regulator of Virulence Genes in Staphylococcus Aureus. Infect. Immun. 73, 1423–1431. doi: 10.1128/IAI.73.3.1423-1431.2005
Jelsbak, L., Hemmingsen, L., Donat, S., Ohlsen, K., Boye, K., Westh, H., et al. (2010). Growth Phase-Dependent Regulation of the Global Virulence Regulator Rot in Clinical Isolates of Staphylococcus Aureus. Int. J. Med. Microbiol. 300, 229–236. doi: 10.1016/j.ijmm.2009.07.003
Jenul, C., Horswill, A. R. (2019). Regulation of Staphylococcus Aureus Virulence. Microbiol. Spectr. 7, 7.2.29. doi: 10.1128/microbiolspec.gpp3-0031-2018
Kerrigan, S. W., Clarke, N., Loughman, A., Meade, G., Foster, T. J., Cox, D. (2008). Molecular Basis for Staphylococcus Aureus-Mediated Platelet Aggregate Formation Under Arterial Shear In Vitro. Arterioscler. Thromb. Vasc. Biol. 28, 335–340. doi: 10.1161/ATVBAHA.107.152058
King, J. M., Kulhankova, K., Stach, C. S., Vu, B. G., Salgado-Pabón, W. (2016). Phenotypes and Virulence Among Staphylococcus Aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages. mSphere 1, e00071-16. doi: 10.1128/msphere.00071-16
Kinney, K. J., Tang, S. S., Wu, X.-J., Tran, P. M., Bharadwaj, N. S., Gibson-Corley, K. N., et al. (2022). SEC is an Anti-Angiogenic Virulence Factor That Promotes Staphylococcus Aureus Infective Endocarditis Independent of Superantigen Activity. Sci. Adv. 8. doi: 10.1101/2019.12.13.875633. in press 11 May 2022. bioRxiv.
Kulhankova, K., Kinney, K. J., Stach, J. M., Gourronc, F. A., Grumbach, I. M., Klingelhutz, A. J., et al. (2018). The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function. Infect. Immun. 86, e00848-17. doi: 10.1128/IAI.00848-17
Kusch, K., Hanke, K., Holtfreter, S., Schmudde, M., Kohler, C., Erck, C., et al. (2011). The Influence of SaeRS and ς B on the Expression of Superantigens in Different Staphylococcus Aureus Isolates. Int. J. Med. Microbiol. 301, 488–499. doi: 10.1016/j.ijmm.2011.01.003
Langley, R. J., Ting, Y. T., Clow, F., Young, P. G., Radcliff, F. J., Choi, J. M., et al. (2017). Staphylococcal Enterotoxin-Like X (SElX) is a Unique Superantigen With Functional Features of Two Major Families of Staphylococcal Virulence Factors. PloS Pathog. 13, e1006549–e1006549. doi: 10.1371/journal.ppat.1006549
Lee, C., Kim, J., Shin, S. G., Hwang, S. (2006). Absolute and Relative qPCR Quantification of Plasmid Copy Number in Escherichia Coli. J. Biotech. 123, 273–280. doi: 10.1016/j.jbiotec.2005.11.014
Le Moing, V., Alla, F., Doco-Lecompte, T., Delahaye, F., Piroth, L., Chirouze, C., et al. (2015). Staphylococcus Aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study. PloS One 10, e0127385. doi: 10.1371/journal.pone.0127385
Lerche, C. J., Schwartz, F., Theut, M., Fosbøl, E. L., Iversen, K., Bundgaard, H., et al. (2021). Anti-Biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome. Front. Cell Dev. Biol. 9. doi: 10.3389/fcell.2021.643335
Li, M., Diep, B. A., Villaruz, A. E., Braughton, K. R., Jiang, X., DeLeo, F. R., et al. (2009). Evolution of Virulence in Epidemic Community-Associated Methicillin-Resistant Staphylococcus Aureus. Proc. Natl. Acad. Sci. U. S. A. 106, 5883–5888. doi: 10.1073/pnas.0900743106
Limbago, B., Fosheim, G. E., Schoonover, V., Crane, C. E., Nadle, J., Petit, S., et al. (2009). Characterization of Methicillin-Resistant Staphylococcus Aureus Isolates Collected in 2005 and 2006 From Patients With Invasive Disease: A Population-Based Analysis. J. Clin. Microbiol. 47, 1344–1351. doi: 10.1128/JCM.02264-08
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., et al. (2000). Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis. Clin. Infect. Dis. 30, 633–638. doi: 10.1086/313753
Lowy, F. D. (1998). Staphylococcus Aureus Infections. N. Engl. J. Med. 339, 520–532. doi: 10.1056/NEJM199808203390806
Luong, T. T., Dunman, P. M., Murphy, E., Projan, S. J., Lee, C. Y. (2006). Transcription Profiling of the mgrA Regulon in Staphylococcus Aureus. J. Bacteriol. 188, 1899–1910. doi: 10.1128/JB.188.5.1899-1910.2006
Malachowa, N., Kohler, P. L., Schlievert, P. M., Chuang, O. N., Dunny, G. M., Kobayashi, S. D., et al. (2011). Characterization of a Staphylococcus Aureus Surface Virulence Factor That Promotes Resistance to Oxidative Killing and Infectious Endocarditis. Infect. Immun. 79, 342–352. doi: 10.1128/IAI.00736-10
Manna, A. C., Bayer, M. G., Cheung, A. L. (1998). Transcriptional Analysis of Different Promoters in the Sar Locus in Staphylococcus Aureus. J. Bacteriol. 180, 3828–3836. doi: 10.1128/jb.180.15.3828-3836.1998
Martini, A. M., Moricz, B. S., Ripperger, A. K., Tran, P. M., Sharp, M. E., Forsythe, A. N., et al. (2020). Association of Novel Streptococcus Sanguinis Virulence Factors With Pathogenesis in a Native Valve Infective Endocarditis Model. Front. Microbiol. 11. doi: 10.3389/fmicb.2020.00010
Mazza, R., Mazzette, R. (2014). “Absolute and Relative Gene Expression in Listeria Monocytogenes Using Real-Time PCR,” in Listeria Monocytogenes, Methods in Molecular Biology (Methods and Protocols). Eds. Jordan, K., Fox, E., Wagner, M. (New York: NY: Humana Press), 213–221.
McAdow, M., Kim, H. K., DeDent, A. C., Hendrickx, A. P. A., Schneewind, O., Missiakas, D. M. (2011). Preventing Staphylococcus Aureus Sepsis Through the Inhibition of its Agglutination in Blood. PloS Pathog. 7, e1002307. doi: 10.1371/journal.ppat.1002307
McDevitt, D., Francois, P., Vaudaux, P., Foster, T. J. (1995). Identification of the Ligand-Binding Domain of the Surface-Located Fibrinogen Receptor (Clumping Factor) of Staphylococcus Aureus. Mol. Microbiol. 16, 895–907. doi: 10.1111/j.1365-2958.1995.tb02316.x
Mcnamara, P. J., Milligan-Monroe, K. C., Khalili, S., Proctor, R. A. (2000). Identification, Cloning, and Initial Characterization of Rot, a Locus Encoding a Regulator of Virulence Factor Expression in Staphylococcus Aureus. J. Bacteriol. 182, 3197–3203. doi: 10.1128/JB.182.11.3197-3203.2000
Montgomery, C. P., Boyle-Vavra, S., Daum, R. S. (2010). Importance of the Global Regulators Agr and SaeRS in the Pathogenesis of CA-MRSA USA300 Infection. PloS One 5, e15177–e15177. doi: 10.1371/journal.pone.0015177
Moreau, K., Clemenceau, A., Le Moing, V., Messika-Zeitoun, D., Andersen, P. S., Bruun, N. E., et al. (2018). Human Genetic Susceptibility to Native Valve Staphylococcus Aureus Endocarditis in Patients With Staphylococcus Aureus Bacteremia: Genome-Wide Association Study. Front. Microbiol. 9. doi: 10.3389/fmicb.2018.00640
Morrison, J. M., Anderson, K. L., Beenken, K. E., Smeltzer, M. S., Dunman, P. M. (2012). The Staphylococcal Accessory Regulator, SarA, is an RNA-Binding Protein That Modulates the mRNA Turnover Properties of Late-Exponential and Stationary Phase Staphylococcus Aureus Cells. Front. Cell. Infect. Microbiol. 2. doi: 10.3389/fcimb.2012.00026
Nienaber, J. J. C., Sharma Kuinkel, B. K., Clarke-Pearson, M., Lamlertthon, S., Park, L., Rude, T. H., et al. (2011). Methicillin-Susceptible Staphylococcus Aureus Endocarditis Isolates are Associated With Clonal Complex 30 Genotype and a Distinct Repertoire of Enterotoxins and Adhesins. J. Infect. Dis. 204, 704–713. doi: 10.1093/infdis/jir389
Patti, J. M., Allen, B. L., McGavin, M. J., Hook, M. (1994). MSCRAMM-Mediated Adherence of Microorganisms to Host Tissues. Annu. Rev. Microbiol. 48, 585–617. doi: 10.1146/annurev.mi.48.100194.003101
Pérez-Montarelo, D., Viedma, E., Larrosa, N., Gómez-González, C., De Gopegui, E. R., Muñoz-Gallego, I., et al. (2018). Molecular Epidemiology of Staphylococcus Aureus Bacteremia: Association of Molecular Factors With the Source of Infection. Front. Microbiol. 9. doi: 10.3389/fmicb.2018.02210
Que, Y. A., Haefliger, J. A., Piroth, L., François, P., Widmer, E., Entenza, J. M., et al. (2005). Fibrinogen and Fibronectin Binding Cooperate for Valve Infection and Invasion in Staphylococcus Aureus Experimental Endocarditis. J. Exp. Med. 201, 1627–1635. doi: 10.1084/jem.20050125
Rechtin, T. M., Gillaspy, A. F., Schumacher, M. A., Brennan, R. G., Smeltzer, M. S., Hurlburt, B. K. (1999). Characterization of the SarA Virulence Gene Regulator of Staphylococcus Aureus. Mol. Microbiol. 33, 307–316. doi: 10.1046/j.1365-2958.1999.01474.x
Recsei, P., Kreiswirth, B., O’Reilly, M., Schlievert, P., Gruss, A., Novick, R. P. (1986). Regulation of Exoprotein Gene Expression in Staphylococcus Aureus by Agr. MGG. Mol. Gen. Genet. 202, 58–61. doi: 10.1007/BF00330517
Roberts, J. C. (2013). Community-Associated Methicillin-Resistant Staphylococcus Aureus Epidemic Clone USA100; More Than a Nosocomial Pathogen. Springerplus 2, 1–3. doi: 10.1186/2193-1801-2-133
Saïd-Salim, B., Dunman, P. M., McAleese, F. M., Macapagal, D., Murphy, E., McNamara, P. J., et al. (2003). Global Regulation of Staphylococcus Aureus Genes by Rot. J. Bacteriol. 185, 610–619. doi: 10.1128/JB.185.2.610-619.2003
Salgado-Pabón, W., Breshears, L., Spaulding, A. R., Merriman, J. A., Stach, C. S., Horswill, A. R., et al. (2013). Superantigens are Critical for Staphylococcus Aureus Infective Endocarditis, Sepsis, and Acute Kidney Injury. MBio 4, e00494-13. doi: 10.1128/mBio.00494-13
Salgado-Pabón, W., Case-Cook, L. C., Schlievert, P. M. (2014). “Molecular Analysis of Staphylococcal Superantigens,” in Methods in Molecular Biology. Ed. Ji, Y. (Totowa: NJ: Humana Press), 169–185. doi: 10.1007/978-1-62703-664-1_10
Schmidt, K. A., Donegan, N. P., Kwan, W. A., Cheung, A. (2004). Influences of ςb and Agr on Expression of Staphylococcal Enterotoxin B (SEB) in Staphylococcus Aureus. Can. J. Microbiol. 50, 351–360. doi: 10.1139/w04-017
Seidl, K., Chen, L., Bayer, A. S., Hady, W. A., Kreiswirth, B. N., Xiong, Y. Q. (2011). Relationship of Agr Expression and Function With Virulence and Vancomycin Treatment Outcomes in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus Aureus. Antimicrob. Agents Chemother. 55, 5631–5639. doi: 10.1128/AAC.05251-11
Selton-Suty, C., Célard, M., Le Moing, V., Doco-Lecompte, T., Chirouze, C., Iung, B., et al. (2012). Preeminence of Staphylococcus Aureus in Infective Endocarditis: A 1-Year Population-Based Survey. Clin. Infect. Dis. 54, 1230–1239. doi: 10.1093/cid/cis199
Shorr, A. F., Tabak, Y. P., Killian, A. D., Gupta, V., Liu, L. Z., Kollef, M. H. (2006). Healthcare-Associated Bloodstream Infection: A Distinct Entity? Insights From a Large U.S. Database. Crit. Care Med. 34, 2588–2595. doi: 10.1097/01.CCM.0000239121.09533.09
Sihto, H. M., Tasara, T., Stephan, R., Johler, S. (2014). Validation of Reference Genes for Normalization of qPCR mRNA Expression Levels in Staphylococcus Aureus Exposed to Osmotic and Lactic Acid Stress Conditions Encountered During Food Production and Preservation. FEMS Microbiol. Lett. 356, 134–140. doi: 10.1111/1574-6968.12491
Sinha, B., François, P. P., Nüße, O., Foti, M., Hartford, O. M., Vaudaux, P., et al. (1999). Fibronectin-Binding Protein Acts as Staphylococcus Aureus Invasin via Fibronectin Bridging to Integrin α5β1. Cell. Microbiol. 1, 101–117. doi: 10.1046/j.1462-5822.1999.00011.x
Somerville, G. A., Proctor, R. A. (2009). At the Crossroads of Bacterial Metabolism and Virulence Factor Synthesis in Staphylococci. Microbiol. Mol. Biol. Rev. 73, 233–248. doi: 10.1128/mmbr.00005-09
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., Schlievert, P. M. (2013). Staphylococcal and Streptococcal Superantigen Exotoxins. Clin. Microbiol. Rev. 26, 422–447. doi: 10.1128/CMR.00104-12
Stach, C. S., Vu, B. G., Merriman, J. A., Herrera, A., Cahill, M. P., Schlievert, P. M., et al. (2016). Novel Tissue Level Effects of the Staphylococcus Aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis. PloS One 11, e0154762–e0154762. doi: 10.1371/journal.pone.0154762
Tegmark, K., Karlsson, A., Arvidson, S. (2000). Identification and Characterization of SarH1, a New Global Regulator of Virulence Gene Expression in Staphylococcus Aureus. Mol. Microbiol. 37, 398–409. doi: 10.1046/j.1365-2958.2000.02003.x
Tenover, F. C., McAllister, S., Fosheim, G., McDougal, L. K., Carey, R. B., Limbago, B., et al. (2008). Characterization of Staphylococcus Aureus Isolates From Nasal Cultures Collected From Individuals in the United States in 2001 to 2004. J. Clin. Microbiol. 46, 2837–2841. doi: 10.1128/JCM.00480-08
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., Fowler, V. G. (2015). Staphylococcus Aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clin. Microbiol. Rev. 28, 603–661. doi: 10.1128/CMR.00134-14
Tran, P. M., Tang, S. S., Salgado-Pabón, W. (2022). Staphylococcus Aureus β-Toxin Exerts Anti-Angiogenic Effects by Inhibiting Re-Endothelialization and Neovessel Formation. Front. Microbiol. 13. doi: 10.3389/fmicb.2022.840236
Tseng, C. W., Stewart, G. C. (2005). Rot Repression of Enterotoxin B Expression in Staphylococcus Aureus. J. Bacteriol. 187, 5301–5309. doi: 10.1128/JB.187.15.5301-5309.2005
Tuffs, S. W., Herfst, C. A., Baroja, M. L., Podskalniy, V. A., DeJong, E. N., Coleman, C. E. M., et al. (2019). Regulation of Toxic Shock Syndrome Toxin-1 by the Accessory Gene Regulator in Staphylococcus Aureus is Mediated by the Repressor of Toxins. Mol. Microbiol. 112, 1163–1177. doi: 10.1111/mmi.14353
Valihrach, L., Demnerova, K. (2012). Impact of Normalization Method on Experimental Outcome Using RT-qPCR in Staphylococcus Aureus. J. Microbiol. Methods 90, 214–216. doi: 10.1016/j.mimet.2012.05.008
Vanassche, T., Kauskot, A., Verhaegen, J., Peetermans, W. E., van Ryn, J., Schneewind, O., et al. (2012). Fibrin Formation by Staphylothrombin Facilitates Staphylococcus Aureus-Induced Platelet Aggregation. Thromb. Haemost. 107, 1107–1121. doi: 10.1160/TH11-12-0891
Vernachio, J., Bayer, A. S., Le, T., Chai, Y. L., Prater, B., Schneider, A., et al. (2003). Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-Resistant Staphylococcus Aureus Bacteremia in an Experimental Model of Infective Endocarditis. Antimicrob. Agents Chemother. 47, 3400–3406. doi: 10.1128/AAC.47.11.3400-3406.2003
Werdan, K., Dietz, S., Löffler, B., Niemann, S., Bushnaq, H., Silber, R. E., et al. (2014). Mechanisms of Infective Endocarditis: Pathogen-Host Interaction and Risk States. Nat. Rev. Cardiol. 11, 35–50. doi: 10.1038/nrcardio.2013.174
Wyllie, D. H., Crook, D. W., Peto, T. E. A. (2006). Mortality After Staphylococcus Aureus Bacteraemia in Two Acute Hospitals in Oxfordshire 1997-2003: Cohort Study. Br. Med. J. 333, 281–284. doi: 10.1136/bmj.38834.421713.2F
Xiong, Y. Q., Fowler, J. V.G., Yeaman, M. R., Perdreau-Remington, F., Kreiswirth, B. N., Bayer, A. S. (2009). Phenotypic and Genotypic Characteristics of Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia In Vitro and in an Experimental Endocarditis Model. J. Infect. Dis. 199, 201–208. doi: 10.1086/595738
Zhao, H., Xu, S., Yang, H., He, C., Xu, X., Hu, F., et al. (2019). Molecular Typing and Variations in Amount of Tst Gene Expression of TSST-1-Producing Clinical Staphylococcus Aureus Isolates. Front. Microbiol. 10, 1388. doi: 10.3389/fmicb.2019.01388
Keywords: staphylococcus aureus, endocarditis, AGR, RNAIII, SarA, CC5
Citation: Kinney KJ, Stach JM, Kulhankova K, Brown M and Salgado-Pabón W (2022) Vegetation Formation in Staphylococcus Aureus Endocarditis Inversely Correlates With RNAIII and sarA Expression in Invasive Clonal Complex 5 Isolates. Front. Cell. Infect. Microbiol. 12:925914. doi: 10.3389/fcimb.2022.925914
Received: 22 April 2022; Accepted: 14 June 2022;
Published: 04 July 2022.
Edited by:
Christiane Wolz, University of Tübingen, GermanyReviewed by:
Chia Y Lee, University of Arkansas for Medical Sciences, United StatesTom Grunert, University of Veterinary Medicine Vienna, Austria
Copyright © 2022 Kinney, Stach, Kulhankova, Brown and Salgado-Pabón. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wilmara Salgado-Pabón, wsalgado@wisc.edu
†Present address: Kyle J. Kinney, Integrated DNA Technologies, Coralville, IA, United States
Jessica M. Stach, Senda Biosciences, Cambridge, MA, United States
Katarina Kulhankova, Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA, United States
Matthew Brown, Laboratory Corporation of America Holdings, Burlington, NC, United States